Related Experiment Videos

Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated

P Jarolim1, H L Rubin, V Brabec

  • 1Department of Biomedical Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135.

Blood
|February 1, 1995
PubMed

Insights

Mutations in the band 3 protein cause hereditary spherocytosis (HS). Specific arginine substitutions prevent band 3 protein incorporation into red blood cell membranes, leading to band 3 deficiency in HS patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Hereditary spherocytosis (HS) is a genetic blood disorder.
  • Band 3 protein is crucial for red blood cell membrane integrity.
  • A subset of HS patients exhibits band 3 deficiency.

Purpose of the Study:

  • To identify the molecular basis of band 3 deficiency in hereditary spherocytosis.
  • To investigate the impact of specific band 3 mutations on protein localization.

Main Methods:

  • Screening of band 3 cDNA for single-strand conformation polymorphism (SSCP).
  • Analysis of mutation inheritance patterns in HS patients.
  • Utilizing a band 3 polymorphism (band 3 Memphis) to track mutant protein incorporation.

Main Results:

  • Identified four arginine substitutions (R760W, R760Q, R808C, R870W) in 29% of HS patients with band 3 deficiency.
  • These mutations were coinherited with the HS phenotype.
  • Demonstrated that the R760Q mutation prevents the mutant band 3 protein from being incorporated into the red blood cell membrane.

Conclusions:

  • Arginine substitutions in band 3 protein disrupt its membrane insertion.
  • This disruption leads to band 3 deficiency in hereditary spherocytosis.
  • Mutant protein loss may occur during erythroid precursor differentiation.

Related Concept Videos